Safety and tolerability of tirbanibulin for the treatment of actinic keratosis (AK): Results from clinical trials and post-registration

tirbanibulin oral (KX2-391 oral) - Athenex

https://eposters.aad.org/abstracts/64609

Andrew Blauvelt MD, MBA; Mark Lebwohl MD; Todd Schlesinger MD; Carola Berking MD; Andrea Conti MD; Edward Lain MD; George Martin MD; Yolanda Gilaberte MD, PhD; Raidah Salem PharmD, MBA; Paul Tomondy PharmD; Neal Bhatia MD

Feb 26, 2025